T. Rowe Price Health Sciences Fund, Inc. VRTX Holdings History
T. Rowe Price Health Sciences Fund, Inc.'s Vertex Pharmaceuticals Inc Holding Summary
As of 2025-03-31, T. Rowe Price Health Sciences Fund, Inc. held 832,087.00 shares of Vertex Pharmaceuticals Inc(VRTX), totaling $403.41 Mil. This investment constitutes 3.54% of their stock portfolio, and T. Rowe Price Health Sciences Fund, Inc. now holds 0.32% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.
The initial trade took place in 2019Q3. And since then T. Rowe Price Health Sciences Fund, Inc. has made 5 purchases of VRTX, at an average price of $190.33, for a total of 2.96 Mil shares. In addition, there have been 7 sales at an average price of $283.17 for 2.12 Mil shares. Based on historical transaction data and VRTX's current price of $477.66, T. Rowe Price Health Sciences Fund, Inc.'s estimated gain on his VRTX holdings is $436.22 Mil, reflecting a 77.54% gain to date.
T. Rowe Price Health Sciences Fund, Inc. VRTX ($477.66) Holding Chart
T. Rowe Price Health Sciences Fund, Inc. VRTX ($477.66) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
